Corresponding Author: Mengtao Zhou and Jianjian Zheng

Department of Surgery, Key Laboratory of Diagnosis and Treatment of Severe Hepato- Pancreatic Diseases, The First Affiliated Hospital of Wenzhou Medical University (China)
E-Mail zmt0417@hotmail.com; 120378196@qq.com


Erratum

In the article “MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition” [Cell Physiol Biochem 2018;46:82-92. DOI: 10.1159/000488411] by Zhou et al., the representative images in Figure 2B for the CCl4+Lenti-miR-NC group was erroneously selected from CCl4 group due to authors' selection of the wrong folder when preparing the figures.

The corrected Figure 2 is shown here.

Fig. 2. Restoring of miR-30a inhibits the progression of liver fibrosis in CCl4 rats. (A and B) Collagen expression and α-SMA level were assessed by Masson staining and immunohistochemistry, respectively. Scale bar, 100 µm. (C) The mRNA levels of α-SMA and Col1A1. (D) ALT value. (E) miR-30a in the livers of CCl4 rats with miR-30a over-expression and (F) in primary HSCs isolated from CCl4 rats with miR-30a over-expression. (G) The protein levels of GFAP and TGF-β1 were analyzed in primary HSCs isolated from CCl4 rats with miR-30a over-expression. GAPDH was used as internal control. *P<0.05.